Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Foreign Aid Donors Should Prioritize Maternal Mortality In Developing Countries, NYT Opinion Piece Says
One of the "most lethal forms of sex discrimination" is the "systematic inattention to reproductive health care, from family planning to childbirth" in developing countries, New York Times columnist Nicholas Kristof writes. According to Kristof, a woman dies every minute somewhere in the world from pregnancy or childbirth complications, and 20 times that number suffer childbirth injuries. Providers of foreign aid, including the U.S., "have never shown much interest in maternal mortality, and impoverished women are typically the most voiceless, neglected people in their own countries -- so they die at astonishing rates," Kristof writes.Kristof highlights the childbirth experience of a 19-year-old Pakistani woman named Shazia Allahdita whose infant died in childbirth after her relatives refused to take her to the hospital because they did not want to pay for the taxi fare. Kristof writes that "[i]f men had uteruses, "paternity wards" would get res, ambulances would transport pregnant men to hospitals free of charge, deliveries would be free, and the Group of Eight industrialized nations would make paternal mortality a top priority." Kristof notes that there is "the dawn of a global movement against maternal mortality," with British Prime Minister Gordon Brown and U.N. Secretary-General Ban Ki-moon working with the U.S. and other countries to plan a "landmark global health session" on Sept. 23. The session will focus, in part, on maternal health, which Kristof terms a "milestone." He concludes, "My dream is that Barack and Michelle Obama will leap forward and adopt this cause -- and transform the prospects for so many young women like Shazia" (Kristof, New York Times, 7/29).

What Is Bell's Palsy? What Causes Bell's Palsy?
Bell"s palsy is either weakness or paralysis of the muscles on one side of the face due to malfunction of the facial nerve. It usually starts suddenly - somebody can wake up in the morning and find that one side of the face does not move. Sometimes one eyelid may be affected, meaning that the patient is unable to blink properly from one eye.
News of the day
10 Years Younger Live - A New Live Event Launches This Summer 3-5th July
10 Years Younger, the cult Channel 4 programme with viewing figures in excess of 10 million viewers, will launch it"s first live event at Earls Court from 3rd - 5th July 09, bringing the cream of "feel good" fashion, beauty and well-being brands to the UK"s real women.
Oncology

Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)

Cobalis Corporation (OTC:CLSC) was recently awarded two additional International Patents in Canada and Mexico and has a patent pending application in Japan. PreHistin® is patented, safe for long-term daily use and available without a prescription. It is available in a cherry flavored, all natural, proprietary cyanocobalamin (vitamin B12) sub-lingual lozenge that is taken twice daily to regulate allergy sufferers" response to both indoor and outdoor allergens with daily and year round usage. Cobalis representatives indicate, "Cyanocobalamin has an excellent safety record, has been safety accepted by the US FDA, and has no upper dosage limits or contra-drug indications. For over 50 years the FDA has approved cyanocobalamin as a drug for anemia. Each PreHistin® lozenge contains 3.3mg Cyanocobalamin. For less than $1.00 per day, twice daily use of PreHistin® has been clinically shown to significantly increase serum vitamin B12 levels, making PreHistin® a cost effective and convenient alternative to other Vitamin B12 therapies, including needle injections." Cobalis Board Member, Dr. Kevin Prendiville states, "These new patents, in addition to the European Union, Australian and two U.S. patents further strengthen the value and assets of Cobalis Corporation intellectual properties. Furthermore, PreHistin®"s box, labeling and related box insert have been approved by DSHEA (Dietary Supplement Health and Education Act) regulation attorneys." About Cobalis Corp-Prehistin® "The World"s First Pre-Histamine" Headquartered in Irvine, California, Cobalis Corp. is an over the counter pharmaceutical and nutraceutical company. Its flagship product, PreHistin® is designed to prevent the primary causes of airborne allergies. PreHistin®, "The World"s First Pre-Histamine" is the only Phase III clinically tested sublingual product fully patented for long term and daily use without a prescription to help relieve allergy sufferers of both indoor and outdoor allergens. PreHistin® is manufactured by Monarch Nutraceutical Inc., a division of Nutraceutical Corporation in Ogden Utah. Nutraceutical Corp. (NUTR) was the original manufacturer of PreHistin® under the name Alleratin, which was distributed to thousands of allergy suffers without cost for compassionate use. Additional PreHistin® manufacturing partners include Marrs Printing, Walnut, CA and Merical Inc, Anaheim, CA. Domestic and international PreHistin® orders are currently fulfilled by International Sales and Marketing (ISM), Newark, NJ. For product information and ordering please visit at http://www.PreHistin.comor call toll free 1-877-4POLLEN. For additional company information please visit their website at http://www.Cobalis.com Cobalis Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009